triazoles has been researched along with Dermatoses in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Balau, B; Bourlond, F; De Glas, V; Diaz, P; Liu, H; Paller, AS; Poumay, Y; Veit, JGS | 1 |
| El Amri, C; Furio, L; Hovnanian, A; Reboud-Ravaux, M; Tan, X; Villoutreix, BO | 1 |
| Fraser, K | 1 |
| Al Mohajer, M; Beatty, N | 1 |
| Goto, S; Itoh, H; Nagai, M; Ohmori, K; Osada, H; Sasaki, K; Shimizu, S; Shimoda, M; Shirai, J; Watanabe, M | 1 |
| George, E; Shinohara, MM | 1 |
| Chen, R; Liao, W; Yao, Z | 1 |
| Johnson, JR; Kelly, R; Mann, BS; Pazdur, R; Sridhara, R; Williams, G | 1 |
| Scheinfeld, N | 1 |
| Blayac, JP; Cociglio, M; Djezzar, S; Eiden, C; Hansel, S; Hillaire-Buys, D; Peyrière, H | 1 |
| Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A | 1 |
| Kagoshima, M; Komatsu, H; Okumoto, T; Tomomatsu, N; Yamaguchi, S | 1 |
| Iwahisa, Y; Okamoto, H; Terasawa, M | 1 |
| Gaines, TB; Kimbrough, RD; Linder, RE | 1 |
2 review(s) available for triazoles and Dermatoses
| Article | Year |
|---|---|
Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.
Topics: Benzothiazoles; Cell Differentiation; Cytochrome P-450 Enzyme Inhibitors; Epidermis; Humans; Keratinocytes; Retinoic Acid 4-Hydroxylase; Skin Diseases; Triazoles | 2021 |
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Topics: Animals; Antineoplastic Agents; Benzoates; Boronic Acids; Bortezomib; Cyclosporine; Dasatinib; Deferasirox; Humans; Iron Chelating Agents; Ophthalmic Solutions; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Thiazoles; Triazoles | 2007 |
13 other study(ies) available for triazoles and Dermatoses
| Article | Year |
|---|---|
1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases.
Topics: Cell Survival; Enzyme Activation; Enzyme Inhibitors; Humans; Kallikreins; Keratinocytes; Skin Diseases; Triazoles | 2013 |
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |
Primary cutaneous mucormycosis developing after incision and drainage of a subcutaneous abscess in an immunocompetent host.
Topics: Abscess; Adult; Amphotericin B; Antifungal Agents; Drainage; Humans; Immunocompetence; Leg; Male; Methicillin-Resistant Staphylococcus aureus; Mucormycosis; Postoperative Complications; Skin Diseases; Staphylococcal Infections; Triazoles | 2016 |
Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
Topics: Animals; Azepines; Dogs; Edema; Erythema; Histamine; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prednisolone; Receptors, G-Protein-Coupled; Skin; Skin Diseases; Triazoles | 2016 |
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole | 2009 |
Management of cryptococcosis in non-HIV-related patients.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles | 2005 |
Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Approval; Female; Follow-Up Studies; Headache; Humans; Letrozole; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Skin Diseases; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; United States; United States Food and Drug Administration | 2005 |
Voriconazole: serious adverse effects and interactions.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Drug Interactions; France; Heart Diseases; Humans; Mental Disorders; Pyrimidines; Skin Diseases; Triazoles; Vision Disorders | 2007 |
Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Drug Interactions; Female; France; Humans; Liver Function Tests; Male; Middle Aged; Pyrimidines; Skin Diseases; Triazoles; Vision Disorders; Voriconazole | 2007 |
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice.
Topics: Animals; Azepines; Cytokines; Eosinophilia; Hypersensitivity; Male; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Skin Diseases; Triazoles | 1999 |
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor.
Topics: Animals; Arthus Reaction; Azepines; Capillary Permeability; Disease Models, Animal; Female; Guinea Pigs; Male; Molecular Structure; Ovalbumin; Pancreatitis; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Skin; Skin Diseases; Triazoles | 1992 |
The toxicity of amitrole in the rat.
Topics: Amitrole; Animals; Body Weight; Diet; Female; Herbicides; Hyperplasia; Intubation, Gastrointestinal; Kidney; Liver; Male; Microscopy, Electron; Organ Size; Pyelonephritis; Rats; Reproduction; Sex Factors; Skin Diseases; Spleen; Thyroid Gland; Triazoles | 1973 |